Cargando…

Quality of life of patients with rheumatic diseases during the COVID-19 pandemic: The biopsychosocial path

BACKGROUND: Previous models that assess quality-of-Life (QoL) in patients with rheumatic diseases have a strong biomedical focus. We evaluated the impact of COVID-19 related-health care interruption (HCI) on the physical, psychological, social relationships and environment QoL-dimensions, and explor...

Descripción completa

Detalles Bibliográficos
Autores principales: Guaracha-Basáñez, Guillermo A., Contreras-Yáñez, Irazú, Hernández-Molina, Gabriela, Estrada-González, Viviana A., Pacheco-Santiago, Lexli D., Valverde-Hernández, Salvador S., Galindo-Donaire, José Roberto, Peláez-Ballestas, Ingris, Pascual-Ramos, Virginia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765619/
https://www.ncbi.nlm.nih.gov/pubmed/35041692
http://dx.doi.org/10.1371/journal.pone.0262756
_version_ 1784634354285150208
author Guaracha-Basáñez, Guillermo A.
Contreras-Yáñez, Irazú
Hernández-Molina, Gabriela
Estrada-González, Viviana A.
Pacheco-Santiago, Lexli D.
Valverde-Hernández, Salvador S.
Galindo-Donaire, José Roberto
Peláez-Ballestas, Ingris
Pascual-Ramos, Virginia
author_facet Guaracha-Basáñez, Guillermo A.
Contreras-Yáñez, Irazú
Hernández-Molina, Gabriela
Estrada-González, Viviana A.
Pacheco-Santiago, Lexli D.
Valverde-Hernández, Salvador S.
Galindo-Donaire, José Roberto
Peláez-Ballestas, Ingris
Pascual-Ramos, Virginia
author_sort Guaracha-Basáñez, Guillermo A.
collection PubMed
description BACKGROUND: Previous models that assess quality-of-Life (QoL) in patients with rheumatic diseases have a strong biomedical focus. We evaluated the impact of COVID-19 related-health care interruption (HCI) on the physical, psychological, social relationships and environment QoL-dimensions, and explored factors associated with QoL when patients were reincorporated to the outpatient clinic, and after six-month follow-up. PATIENTS AND METHODS: Study phase-1 consisted of a COVID-19 survey administered from June 24(th)-October 31(st) 2020, to outpatients with rheumatic diseases who had face-to-face consultation at outpatient clinic reopening. Study phase-2 consisted of 3 consecutive assessments of patient´s QoL (WHOQOL-BREF), disease activity/severity (RAPID-3), and psychological comorbidity/trauma (DASS-21 and IES-R) to patients from phase-1 randomly selected. Sociodemographic, disease and treatment-related information, and comorbidities were obtained. Multiple linear regression analysis identified factors associated with the score assigned to each WHOQOL-BREF dimension. RESULTS: Patients included (670 for phase-1 and 276 for phase-2), had primarily SLE and RA (44.2% and 34.1%, respectively), and all the dimensions of their WHOQOL-BREF were affected. There were 145 patients (52.5%) who referred HCI, and they had significantly lower dimensions scores (but the environment dimension score). Psycho-emotional factors (primarily feeling confused, depression and anxiety), sociodemographic factors (age, COVID-19 negative economic impact, years of scholarship, HCI and having a job), and biomedical factors (RAPID-3 score and corticosteroid use) were associated with baseline QoL dimensions scores. Psycho-emotional factors showed the strongest magnitude on dimensions scores. Most consistent predictor of six-month follow-up QoL dimensions scores was each corresponding baseline dimension score, while social determinants (years of scholarship and having a job), emotional factors (feeling bored), and biomedical aspects (RAPID 3) had an additional impact. CONCLUSIONS: HCI impacted the majority of patient´s QoL dimensions. Psycho-emotional, sociodemographic and biomedical factors were consistently associated with QoL dimensions scores, and these consistently predicted the QoL trajectory.
format Online
Article
Text
id pubmed-8765619
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-87656192022-01-19 Quality of life of patients with rheumatic diseases during the COVID-19 pandemic: The biopsychosocial path Guaracha-Basáñez, Guillermo A. Contreras-Yáñez, Irazú Hernández-Molina, Gabriela Estrada-González, Viviana A. Pacheco-Santiago, Lexli D. Valverde-Hernández, Salvador S. Galindo-Donaire, José Roberto Peláez-Ballestas, Ingris Pascual-Ramos, Virginia PLoS One Research Article BACKGROUND: Previous models that assess quality-of-Life (QoL) in patients with rheumatic diseases have a strong biomedical focus. We evaluated the impact of COVID-19 related-health care interruption (HCI) on the physical, psychological, social relationships and environment QoL-dimensions, and explored factors associated with QoL when patients were reincorporated to the outpatient clinic, and after six-month follow-up. PATIENTS AND METHODS: Study phase-1 consisted of a COVID-19 survey administered from June 24(th)-October 31(st) 2020, to outpatients with rheumatic diseases who had face-to-face consultation at outpatient clinic reopening. Study phase-2 consisted of 3 consecutive assessments of patient´s QoL (WHOQOL-BREF), disease activity/severity (RAPID-3), and psychological comorbidity/trauma (DASS-21 and IES-R) to patients from phase-1 randomly selected. Sociodemographic, disease and treatment-related information, and comorbidities were obtained. Multiple linear regression analysis identified factors associated with the score assigned to each WHOQOL-BREF dimension. RESULTS: Patients included (670 for phase-1 and 276 for phase-2), had primarily SLE and RA (44.2% and 34.1%, respectively), and all the dimensions of their WHOQOL-BREF were affected. There were 145 patients (52.5%) who referred HCI, and they had significantly lower dimensions scores (but the environment dimension score). Psycho-emotional factors (primarily feeling confused, depression and anxiety), sociodemographic factors (age, COVID-19 negative economic impact, years of scholarship, HCI and having a job), and biomedical factors (RAPID-3 score and corticosteroid use) were associated with baseline QoL dimensions scores. Psycho-emotional factors showed the strongest magnitude on dimensions scores. Most consistent predictor of six-month follow-up QoL dimensions scores was each corresponding baseline dimension score, while social determinants (years of scholarship and having a job), emotional factors (feeling bored), and biomedical aspects (RAPID 3) had an additional impact. CONCLUSIONS: HCI impacted the majority of patient´s QoL dimensions. Psycho-emotional, sociodemographic and biomedical factors were consistently associated with QoL dimensions scores, and these consistently predicted the QoL trajectory. Public Library of Science 2022-01-18 /pmc/articles/PMC8765619/ /pubmed/35041692 http://dx.doi.org/10.1371/journal.pone.0262756 Text en © 2022 Guaracha-Basáñez et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Guaracha-Basáñez, Guillermo A.
Contreras-Yáñez, Irazú
Hernández-Molina, Gabriela
Estrada-González, Viviana A.
Pacheco-Santiago, Lexli D.
Valverde-Hernández, Salvador S.
Galindo-Donaire, José Roberto
Peláez-Ballestas, Ingris
Pascual-Ramos, Virginia
Quality of life of patients with rheumatic diseases during the COVID-19 pandemic: The biopsychosocial path
title Quality of life of patients with rheumatic diseases during the COVID-19 pandemic: The biopsychosocial path
title_full Quality of life of patients with rheumatic diseases during the COVID-19 pandemic: The biopsychosocial path
title_fullStr Quality of life of patients with rheumatic diseases during the COVID-19 pandemic: The biopsychosocial path
title_full_unstemmed Quality of life of patients with rheumatic diseases during the COVID-19 pandemic: The biopsychosocial path
title_short Quality of life of patients with rheumatic diseases during the COVID-19 pandemic: The biopsychosocial path
title_sort quality of life of patients with rheumatic diseases during the covid-19 pandemic: the biopsychosocial path
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765619/
https://www.ncbi.nlm.nih.gov/pubmed/35041692
http://dx.doi.org/10.1371/journal.pone.0262756
work_keys_str_mv AT guarachabasanezguillermoa qualityoflifeofpatientswithrheumaticdiseasesduringthecovid19pandemicthebiopsychosocialpath
AT contrerasyanezirazu qualityoflifeofpatientswithrheumaticdiseasesduringthecovid19pandemicthebiopsychosocialpath
AT hernandezmolinagabriela qualityoflifeofpatientswithrheumaticdiseasesduringthecovid19pandemicthebiopsychosocialpath
AT estradagonzalezvivianaa qualityoflifeofpatientswithrheumaticdiseasesduringthecovid19pandemicthebiopsychosocialpath
AT pachecosantiagolexlid qualityoflifeofpatientswithrheumaticdiseasesduringthecovid19pandemicthebiopsychosocialpath
AT valverdehernandezsalvadors qualityoflifeofpatientswithrheumaticdiseasesduringthecovid19pandemicthebiopsychosocialpath
AT galindodonairejoseroberto qualityoflifeofpatientswithrheumaticdiseasesduringthecovid19pandemicthebiopsychosocialpath
AT pelaezballestasingris qualityoflifeofpatientswithrheumaticdiseasesduringthecovid19pandemicthebiopsychosocialpath
AT pascualramosvirginia qualityoflifeofpatientswithrheumaticdiseasesduringthecovid19pandemicthebiopsychosocialpath